Health Alert: Legislation that would allow the critically ill to bypass the FDA to obtain experimental medications heads to the White House
The House on Tuesday passed the "right-to-try" legislation, ending a drawn-out battle over access to unapproved therapies. President Trump is expected to quickly sign the measure, which was praised by supporters as a lifeline for desperate patients but denounced by scores of medical and consumer groups as unnecessary and dangerous.
The House on Tuesday passed the "right-to-try" legislation, ending a drawn-out battle over access to unapproved therapies.
President Trump is expected to quickly sign the measure, which was praised by supporters as a lifeline for desperate patients but denounced by scores of medical and consumer groups as unnecessary and dangerous.
No comments:
Post a Comment